Aristo Pharmaceuticals Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Trimegabose 1 mg/500 mg/0.2 mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Trimegabose 1 mg/500 mg/0.2 mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Trimegabose 1 mg/500 mg/0.2 mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Trimegabose 1 mg/500 mg/0.2 mg Tablet.
Trimegabose 1 mg/500 mg/0.2 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Trimegabose 1 mg/500 mg/0.2 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.
Trimegabose 1 mg/500 mg/0.2 mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Trimegabose 1 mg/500 mg/0.2 mg Tablet contains three active ingredients: Glimepiride, Metformin, and Voglibose. This combination medication is used to treat Type 2 Diabetes Mellitus (DM). It helps improve blood glucose levels in adults when taken along with a proper diet and regular exercise. Glimepiride lowers blood sugar by increasing the release of insulin from the pancreas. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor, which lowers postprandial (after meal) glucose levels. This combination medication is not indicated for the treatment of Type 1 DM.
Common side effects associated with Trimegabose 1 mg/500 mg/0.2 mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
The use of Trimegabose 1 mg/500 mg/0.2 mg Tablet should be avoided in individuals with known allergies to any of the components or excipients of this medication. It is also contraindicated for patients with moderate to severe kidney disease and inflammatory bowel diseases, such as ulcerative colitis or Crohn's disease. Additionally, individuals with underlying metabolic acidosis including diabetic ketoacidosis should avoid its use.
No, combining Trimegabose 1 mg/500 mg/0.2 mg Tablet with alcohol is not advisable. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, taking Trimegabose 1 mg/500 mg/0.2 mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur if you miss or delay your meals, drink alcohol, over-exercise, or take other antidiabetic medication along with it. Regular monitoring of blood sugar levels is crucial. Keep glucose tablets, honey, or fruit juice with you at all times.
Store this medication in its original packaging, tightly sealed. Follow the instructions on the product label or package insert. Dispose of unused portions appropriately. Ensure that children, pets, and other individuals do not have access to the medicine.